Učitavanje...

The MYCN-HMGA2-CDKN2A pathway in non-small cell lung carcinoma—differences in histological subtypes

BACKGROUND: Extensive research has increased our understanding of the molecular alterations needed for non-small cell lung cancer (NSCLC) development. Deregulation of a pathway including MYCN, HMGA2 and CDKN2A, with the participation of DICER1, is of importance in several solid tumours, and may also...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:BMC Cancer
Glavni autori: Eide, Hanne A., Halvorsen, Ann Rita, Bjaanæs, Maria Moksnes, Piri, Hossein, Holm, Ruth, Solberg, Steinar, Jørgensen, Lars, Brustugun, Odd Terje, Kiserud, Cecilie Essholt, Helland, Åslaug
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2016
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4746877/
https://ncbi.nlm.nih.gov/pubmed/26858029
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2104-9
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!